Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MIDWEST DIVISION - RMC, LLC

NPI: 1134187842 · KANSAS CITY, MO 64132 · General Acute Care Hospital · NPI assigned 05/02/2006

$56.99M
Total Medicaid Paid
491,666
Total Claims
439,626
Beneficiaries
86
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMAXFIELD, SAMUEL (CFO)
NPI Enumeration Date05/02/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 56,741 $14.33M
2019 62,576 $13.05M
2020 47,871 $7.21M
2021 66,525 $3.28M
2022 89,396 $6.01M
2023 89,871 $6.93M
2024 78,686 $6.19M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 86,225 81,443 $13.51M
X4011 State-specific procedure code 28,497 25,668 $12.57M
99284 Emergency department visit for the evaluation and management, high severity 31,784 29,696 $7.47M
85027 54,132 46,377 $3.12M
81025 29,428 27,857 $2.85M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 6,190 5,235 $1.98M
80053 Comprehensive metabolic panel 40,010 34,055 $1.95M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 13,050 12,037 $1.70M
81003 23,258 21,963 $1.55M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 14,158 12,741 $1.13M
81001 13,334 12,260 $1.05M
99282 Emergency department visit for the evaluation and management, low to moderate severity 7,214 6,950 $786K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 8,244 7,483 $766K
80047 5,891 5,419 $744K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 6,949 6,251 $714K
G0378 Hospital observation service, per hour 665 531 $418K
36415 Collection of venous blood by venipuncture 32,890 27,054 $389K
83690 4,880 4,452 $340K
71045 Radiologic examination, chest; single view 5,753 5,272 $280K
71046 Radiologic examination, chest; 2 views 2,214 2,058 $279K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 7,364 6,447 $276K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,787 1,713 $274K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 5,318 5,110 $266K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5,132 4,928 $259K
87430 4,259 4,076 $245K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1,838 1,052 $245K
70450 Computed tomography, head or brain; without contrast material 2,063 1,855 $212K
87081 2,906 2,768 $183K
Y7506 3,720 2,045 $159K
87086 Culture, bacterial; quantitative colony count, urine 579 541 $147K
84484 6,955 5,296 $124K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2,513 2,375 $122K
96375 Therapeutic injection; each additional sequential IV push 3,759 3,060 $116K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 5,382 4,970 $111K
80076 507 468 $102K
X4003 1,181 802 $87K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,668 1,558 $85K
74177 Computed tomography, abdomen and pelvis; with contrast material 406 381 $78K
85014 305 247 $49K
77336 55 24 $37K
87210 1,510 1,465 $36K
J3490 Unclassified drugs 6,782 5,226 $30K
85610 510 462 $21K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1,079 840 $19K
83880 570 502 $14K
72125 Computed tomography, cervical spine; without contrast material 247 228 $14K
84443 Thyroid stimulating hormone (TSH) 1,323 927 $12K
82378 1,018 639 $10K
80048 Basic metabolic panel (calcium, ionized) 112 89 $10K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 56 53 $10K
82728 1,272 1,038 $7K
83735 1,354 1,140 $5K
87428 207 204 $5K
85730 262 235 $3K
73562 71 67 $3K
73130 56 56 $3K
73610 57 52 $3K
96417 114 55 $2K
83615 777 545 $2K
87070 247 246 $2K
74022 14 14 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 27 27 $1K
99232 Subsequent hospital care, per day, moderate complexity 47 44 $993.82
73630 15 14 $783.19
99238 Hospital discharge day management, 30 minutes or less 16 14 $680.64
86900 12 12 $647.75
86301 43 27 $621.76
84702 51 50 $472.55
87807 42 41 $411.38
96402 13 12 $336.76
86850 12 12 $298.49
86901 12 12 $203.38
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 14 13 $192.50
80306 17 14 $190.69
86300 29 13 $150.03
J2704 Injection, propofol, 10 mg 141 110 $137.97
J0690 Injection, cefazolin sodium, 500 mg 108 77 $122.37
80197 82 41 $99.98
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 14 14 $85.54
84100 137 86 $83.75
J2250 Injection, midazolam hydrochloride, per 1 mg 33 24 $61.13
J1644 Injection, heparin sodium, per 1000 units 64 50 $57.75
82565 15 13 $47.70
J7050 Infusion, normal saline solution, 250 cc 571 266 $16.82
A9270 Non-covered item or service 34 26 $0.00
C1788 Port, indwelling (implantable) 16 13 $0.00